Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,348
datasets available to search
ShareScore release 0.9.0
Dataset results
6,348 results for “Hepatitis”
An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Participants
ClinicalTrials.gov study NCT01290679. IPD Sharing: Not stated. Countries: 15. Publications: 2.
Hepatitis B Booster Study in Adolescence
ClinicalTrials.gov study NCT02169674. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B
ClinicalTrials.gov study NCT03491553. IPD Sharing: NO. Countries: 2. Publications: 1.
Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects
ClinicalTrials.gov study NCT00987337. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System
ClinicalTrials.gov study NCT01777295. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B
ClinicalTrials.gov study NCT02881008. IPD Sharing: NO. Countries: 1. Publications: 6.
Safety and Tolerability of NTR-101 in Patients With Acute Alcohol-Associated Hepatitis
ClinicalTrials.gov study NCT06750588. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of PF-06651600 in Subjects With Hepatic Impairment and Healthy Volunteers
ClinicalTrials.gov study NCT04016077. IPD Sharing: NO. Countries: 1. Publications: 2.
Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study)
ClinicalTrials.gov study NCT02175966. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis
ClinicalTrials.gov study NCT00076336. IPD Sharing: Not stated. Countries: 21. Publications: 0.
A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Gen
ClinicalTrials.gov study NCT01938625. IPD Sharing: Not stated. Countries: 3. Publications: 1.
VX-950-C211 - A Dosing Regimen Study (Twice Daily Versus Every 8 Hours) of Telaprevir in Treatment-naïve Participants With Genotype 1 Chronic Hepatitis C Virus Infection
ClinicalTrials.gov study NCT01241760. IPD Sharing: Not stated. Countries: 13. Publications: 2.
An Integrated Care Model for Improving Hepatitis C Virus Patient Outcomes
ClinicalTrials.gov study NCT00722423. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection
ClinicalTrials.gov study NCT04129554. IPD Sharing: YES. Countries: 7. Publications: 1.
Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease
ClinicalTrials.gov study NCT00529568. IPD Sharing: Not stated. Countries: 23. Publications: 3.
Observational Study Evaluating the Quality of Pegylated Interferon Alfa-2a and Ribavirin Treatment for Chronic Hepatitis C in Cooperation With the BNG (Association of German Resident Gastroenterologis
ClinicalTrials.gov study NCT02106156. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compens
ClinicalTrials.gov study NCT03235349. IPD Sharing: YES. Countries: 2. Publications: 1.
Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver
ClinicalTrials.gov study NCT01146808. IPD Sharing: NO. Countries: 1. Publications: 2.
Efficacy and Safety of MP-424/Peginterferon Alfa-2b/Ribavirin Combination in Treatment-Naïve Patients With Chronic Hepatitis C
ClinicalTrials.gov study NCT00780416. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BI 207127 / Faldaprevir Combination Therapy in Hepatic Impairment (Child-Pugh B) Patients With Genotype 1b Chronic Hepatitis C Infection: HCVerso3
ClinicalTrials.gov study NCT01830127. IPD Sharing: Not stated. Countries: 4. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.